Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

AMS:AZRN - Euronext Amsterdam - NL00150006Z9 - Common Stock - Currency: EUR

1.37  0 (0%)

Fundamental Rating

1

Overall AZRN gets a fundamental rating of 1 out of 10. We evaluated AZRN against 21 industry peers in the Interactive Media & Services industry. AZRN may be in some trouble as it scores bad on both profitability and health. AZRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AZRN had negative earnings in the past year.
In the past year AZRN had a positive cash flow from operations.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -5.18%, AZRN is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
The Return On Equity of AZRN (-51.19%) is worse than 76.19% of its industry peers.
Industry RankSector Rank
ROA -5.18%
ROE -51.19%
ROIC N/A
ROA(3y)-7.52%
ROA(5y)N/A
ROE(3y)-57.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 31.53%, AZRN is doing worse than 76.19% of the companies in the same industry.
AZRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
AZRN has more shares outstanding than it did 1 year ago.
AZRN has a worse debt/assets ratio than last year.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

AZRN has an Altman-Z score of 0.75. This is a bad value and indicates that AZRN is not financially healthy and even has some risk of bankruptcy.
AZRN's Altman-Z score of 0.75 is on the low side compared to the rest of the industry. AZRN is outperformed by 61.90% of its industry peers.
A Debt/Equity ratio of 3.75 is on the high side and indicates that AZRN has dependencies on debt financing.
AZRN has a worse Debt to Equity ratio (3.75) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACCN/A
WACC17.1%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.94 indicates that AZRN may have some problems paying its short term obligations.
AZRN's Current ratio of 0.94 is on the low side compared to the rest of the industry. AZRN is outperformed by 66.67% of its industry peers.
AZRN has a Quick Ratio of 0.94. This is a bad value and indicates that AZRN is not financially healthy enough and could expect problems in meeting its short term obligations.
AZRN has a worse Quick ratio (0.94) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

AZRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -254.90%.
Looking at the last year, AZRN shows a small growth in Revenue. The Revenue has grown by 7.03% in the last year.
EPS 1Y (TTM)-254.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.72%
Revenue 1Y (TTM)7.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.21%

3.2 Future

The Earnings Per Share is expected to grow by 67.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.58% on average over the next years. This is quite good.
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.49%
Revenue Next 2Y9.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZRN. In the last year negative earnings were reported.
Also next year AZRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

AZRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZRN is cheaper than 76.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.2
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AZRN's earnings are expected to grow with 67.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AZRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZERION GROUP N.V.

AMS:AZRN (4/25/2025, 7:00:00 PM)

1.37

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-19 2024-11-19/bmo
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners45.38%
Ins Owner ChangeN/A
Market Cap168.33M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-8.62%
Max Revenue beat(2)10.31%
Revenue beat(4)3
Avg Revenue beat(4)3.72%
Min Revenue beat(4)-8.62%
Max Revenue beat(4)10.31%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-157.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF 24.05
P/B 2.35
P/tB N/A
EV/EBITDA 8.2
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)0.06
OCFY4.16%
SpS4.49
BVpS0.58
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.18%
ROE -51.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.53%
FCFM N/A
ROA(3y)-7.52%
ROA(5y)N/A
ROE(3y)-57.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 43.51%
Cap/Sales 3.77%
Interest Coverage N/A
Cash Conversion 15.42%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 0.75
F-Score3
WACC17.1%
ROIC/WACCN/A
Cap/Depr(3y)51.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-254.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.72%
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.21%
Revenue Next Year9.49%
Revenue Next 2Y9.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-103.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-154.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.97%
OCF growth 3YN/A
OCF growth 5YN/A